概括
与医疗管理相比,对左主冠状动脉疾病的手术治疗显著改善了存活率和心痛缓解. 早期手术干预显示出最明显的生存益处,特别是在患有复杂冠状动脉疾病的患者中.
科学领域:
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
- 临床试验 临床试验
背景情况:
- 左主冠状动脉疾病 (LMCD) 构成突发心脏死亡和心脏不良事件的重大风险.
- 对LMCD的最佳治疗策略仍然是心血管医学研究的关键领域.
研究的目的:
- 为了比较手术复血管化的长期疗效与显著LMCD患者的医疗管理.
- 评估与LMCD不同治疗方法相关的生存率,症状缓解和手术死亡率.
主要方法:
- 来自LMCD前性随机研究中的113名患者子组的分析.
- 随机分配给传统的医疗治疗 (53名患者) 或使用冠状动脉状静脉旁路移植 (60名患者) 的手术治疗.
- 随访时间长达60个月,详细记录死亡率,心痛得分和危险因素.
主要成果:
- 整体死亡率在手术组 (20%) 与医疗组 (36%) 相比较低 (P < 0.06).
- 在手术手臂中,随着时间的推移,手术死亡率显著下降.
- 在过去3年随机选择的患者中,手术治疗在24个月内显示出明显更高的生存率 (7%) 与医疗治疗 (29%) (P < 0.01) 相比.
- 手术干预可以更好地缓解心痛症状.
结论:
- 通过冠状动脉石静脉旁路移植进行手术治疗,为患有严重左主冠状动脉疾病的患者提供了相对于医疗治疗的显著生存优势.
- 手术干预的好处在患有复杂冠状动脉疾病的患者中尤为明显,并且与改善胸痛症状控制有关.
更多相关视频
相关概念视频
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...


